110 related articles for article (PubMed ID: 2674086)
1. Impact of initial quality control review on study outcome in lung and head/neck cancer studies--review of the Radiation Therapy Oncology Group experience.
Wallner PE; Lustig RA; Pajak TF; Robinson G; Davis LW; Perez CA; Seydel HG; Marcial VA; Laramore GE
Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):893-900. PubMed ID: 2674086
[TBL] [Abstract][Full Text] [Related]
2. Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer.
Fu KK; Cooper JS; Marcial VA; Laramore GE; Pajak TF; Jacobs J; Al-Sarraf M; Forastiere AA; Cox JD
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):425-38. PubMed ID: 8655364
[TBL] [Abstract][Full Text] [Related]
3. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the accuracy and clinical practicality of a calculation system for patient positional displacement in carbon ion radiotherapy at five sites.
Kubota Y; Hayashi H; Abe S; Souda S; Okada R; Ishii T; Tashiro M; Torikoshi M; Kanai T; Ohno T; Nakano T
J Appl Clin Med Phys; 2018 Mar; 19(2):144-153. PubMed ID: 29369463
[TBL] [Abstract][Full Text] [Related]
5. Influence of a sampling review process for radiation oncology quality assurance in cooperative group clinical trials--results of the Radiation Therapy Oncology Group (RTOG) analysis.
Martin LA; Krall JM; Curran WJ; Leibel SA; Cox JD
Radiother Oncol; 1995 Jul; 36(1):9-14. PubMed ID: 8525028
[TBL] [Abstract][Full Text] [Related]
6. Quality assurance audit in an Australasian phase III trial of accelerated radiotherapy for head and neck cancer (TROG 91.01). Trans-Tasman Radiation Oncology Group.
Hamilton C; Poulsen M; Walker Q; Krawitz H; Hindley A; Spry N; Peters L; Lamb D; Denham J; Steigler A
Australas Radiol; 1999 May; 43(2):227-32. PubMed ID: 10901907
[TBL] [Abstract][Full Text] [Related]
7. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
8. Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer.
Marcial VA; Pajak TF; Kramer S; Davis LW; Stetz J; Laramore GE; Jacobs JR; Al-Sarraf M; Brady LW
Semin Oncol; 1988 Feb; 15(1):39-60. PubMed ID: 3278390
[TBL] [Abstract][Full Text] [Related]
9. Prospective Qualitative and Quantitative Analysis of Real-Time Peer Review Quality Assurance Rounds Incorporating Direct Physical Examination for Head and Neck Cancer Radiation Therapy.
Cardenas CE; Mohamed ASR; Tao R; Wong AJR; Awan MJ; Kuruvila S; Aristophanous M; Gunn GB; Phan J; Beadle BM; Frank SJ; Garden AS; Morrison WH; Fuller CD; Rosenthal DI
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):532-540. PubMed ID: 28258898
[TBL] [Abstract][Full Text] [Related]
10. Implementation of remote 3-dimensional image guided radiation therapy quality assurance for radiation therapy oncology group clinical trials.
Cui Y; Galvin JM; Parker W; Breen S; Yin FF; Cai J; Papiez LS; Li XA; Bednarz G; Chen W; Xiao Y
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):271-7. PubMed ID: 22541964
[TBL] [Abstract][Full Text] [Related]
11. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.
Sause WT; Scott C; Taylor S; Johnson D; Livingston R; Komaki R; Emami B; Curran WJ; Byhardt RW; Turrisi AT
J Natl Cancer Inst; 1995 Feb; 87(3):198-205. PubMed ID: 7707407
[TBL] [Abstract][Full Text] [Related]
12. Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group.
Johnstone DW; Byhardt RW; Ettinger D; Scott CB
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):365-9. PubMed ID: 12243809
[TBL] [Abstract][Full Text] [Related]
13. [Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
Hideghéty K; Cserháti A; Besenyi Z; Zag L; Gaál S; Együd Z; Mózes P; Szántó E; Csenki M; Rusz O; Varga Z; Dobi Á; Maráz A; Pávics L; Lengyel Z
Magy Onkol; 2015 Jun; 59(2):103-10. PubMed ID: 26035157
[TBL] [Abstract][Full Text] [Related]
14. "Two are better than one": a pilot study of how radiologist and oncologists can collaborate in target volume definition.
Horan G; Roques TW; Curtin J; Barrett A
Cancer Imaging; 2006 Feb; 6(1):16-9. PubMed ID: 16520292
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan clinical oncology group trial (JCOG0403).
Nishio T; Kunieda E; Shirato H; Ishikura S; Onishi H; Tateoka K; Hiraoka M; Narita Y; Ikeda M; Goka T
Phys Med Biol; 2006 Nov; 51(21):5409-17. PubMed ID: 17047260
[TBL] [Abstract][Full Text] [Related]
16. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center.
Garrido-Laguna I; Janku F; Vaklavas C; Falchook GS; Fu S; Hong DS; Naing A; Tsimberidou AM; Wen S; Kurzrock R
Cancer; 2012 Mar; 118(5):1422-8. PubMed ID: 21823111
[TBL] [Abstract][Full Text] [Related]
18. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
19. EPID-based in vivo dosimetry using Dosimetry Check™: Overview and clinical experience in a 5-yr study including breast, lung, prostate, and head and neck cancer patients.
Nailon WH; Welsh D; McDonald K; Burns D; Forsyth J; Cooke G; Cutanda F; Carruthers LJ; McLaren DB; Puxeu Vaqué J; Kehoe T; Andiappa S
J Appl Clin Med Phys; 2019 Jan; 20(1):6-16. PubMed ID: 30536528
[TBL] [Abstract][Full Text] [Related]
20. The evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer.
Byhardt RW
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1513-25. PubMed ID: 7635796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]